Life Science Analytics Market Size, Share & Growth Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy and Others), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer and Others) - Global Industry Analysis, Trends, Segment Forecasts, Regional Outlook 2024 - 2033
The global life science analytics market size was USD 10.15 billion in 2023, accounted for USD 11.02 billion in 2024, and is expected to reach around USD 23.22 billion by 2033, expanding at a CAGR of 8.6% from 2024 to 2033.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. life science analytics market size was estimated at USD 3.71 billion in 2023 and is predicted to be worth around USD 8.88 billion by 2033, at a CAGR of 9.1% from 2024 to 2033.
North America, Europe, Asia Pacific, Latin America and Middle East and Africa are the most common five region covered in the report of life science analytics market. North America is the appeared as dominant regional market among others. The North America region accounted largest revenue share of around 52.14%.
On the other hand, Asia Pacific is expanding at a CAGR of 10.5% over the forecast period. Major players of North America are looking towards the Asia Pacific for their future growth and development. Bulking loads of chronic disorders in the region like North America and Europe is also considered as one of the major driving factors which helps the growth of the global life science analytics market.
Technical upgradation in the field of analytics in the healthcare segment is considered as one of the major driving factors which promote the growth of the life science analytics market.
Furthermore, the rising penetration of big data usage in healthcare is also one of the prime factors for the life science care analytics segment. Data standardization coupled with firm investment in the field of data spending is further accelerating market growth. Rising burden of chronic disorders, increasing workloads on FDA and firm related to the drug approval process are some of the major reasons to support market growth. According to the National Health Council, in the year 2020 more than 157 million Americans are suffering from chronic disorders
Data analytics has always been known for its dealing with mass quantities of information in the various sectors. Increasing digitalization in hospitals, research centers are considered is the prime factor for the development of life science analytics market. Less price of data handling is the most prominent factor which assists in the development of the life science analytics market. Countries like United States, India, and China are experiencing huge amounts of patient data every day. Data-driven technology helps these countries to analyze the healthcare data like patient records, treatment, inventory management, staff data, and all other queries are at a much faster rate compare to the traditional method.
Some of the segments where life science analytics are much helpful are medical imaging, developing new therapies, smart staffing, reducing fraud, risk management, supply chain management and others.
| Report Highlights | Details |
| Market Size in 2023 | USD 10.15 Billion |
| Market Size in 2024 | USD 11.02 Billion |
| Market Size by 2033 | USD 23.22 Billion |
| Growth Rate from 2024 to 2033 | CAGR of 8.6% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Type, Component, Delivery Model, Application, and End Users |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Different types of analytics assessed in this report are descriptive, predictive, diagnostic, discovery, and prescriptive. The descriptive segments held the majority of the market shares in the year 2023. Life science analytics always deals with the description methods to deals with the life sciences queries. For a better explanation and interpretations about the incidence and past trend data, the descriptive analytics provide overviews of the subjects. It is also observed that predictive health analytics proved to be more complex when compared with descriptive analytics. Most healthcare organizations aim to investigate the performance gap and allow the space for preparing the better strategies needed for the organization. Firm preference for descriptive analytics is due to its form or presentation like simple graphs with explanations. The discovery analytics used to discover or determine the different scientific facts. For instance, Centers for Medicare and Medicaid Services (CMS) used analytics to reduce hospital readmission rates.
The predictive analysis is registering growth at a CAGR of 9.2% over the forthcoming years.
Based on the type of component the market is fragmented into, software and services. In 2023, the services segment garnered for a revenue share of around 56%. Service provided by skilled professionals and cloud management services are costlier. These services are mostly provided by companies like Microsoft, clodera and others. The efficient running of the analytics services plays a major role in its execution. The services segment is poised to reach at a CAGR of 8.3% over the forecast period.
By Application, the market is classified into research & development, supply chain optimization, clinical trials, sales & marketing, regulatory compliance, preclinical trials, and pharmacovigilance. The sales and marketing segment dominated the life science analytics market and garnered a revenue share of 31.4% in 2023.
Sales and marketing showed noticeable improvement in recent years and the same will grow at the considerable CAGR within the forecast period. Marketing campaigns and post-marketing surveys become important for the healthcare firm. Market surveillance is also assisted in boosting the life sciences analytics market.
The research and development is expected to hit at a CAGR of 9.9% over the forecast period.
On the basis of end-users, the market is classified into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators. The pharmaceutical and bio-technology are the biggest end-users both in terms of revenue generation and consumption volume. In the year 2023, the same segment held the maximum market share 47%. Life science analytics is used to accelerate the process of discovery and development of the drugs, to optimize the efficacy of clinical trials, to focus on a specific population of the patients, to see the effect of the drug, to analyze the patient behavioral activities over healthcare outcome, and to further manage the patient's safety and risk management. For instance, The Johnson and Johnson Company is looking for the data to assist the pharmaceutical and biotechnological firm for making decision-based process easier.
Biotechnology companies are anticipated to reach at a CAGR of 8.8% over the forthcoming years.
Segments Covered in the Report
By Type
By Component Type
By Delivery Model
By Application Type
By End Users Type
By Regional Outlook
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Life Science Analytics Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Life Science Analytics Market
5.1. Covid-19: Life Science Analytics Industry Impact
5.2. Life Science Analytics Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and Life Science Analytics Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Life Science Analytics Manufacturers to deal with Covid-19 Pandemic Scenario
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Global Life Science Analytics Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Life Science Analytics Market Revenue by Manufacturer
7.1.1.2. Life Science Analytics Market Revenue Market Share by Manufacturer
7.1.1.3. Life Science Analytics Market Production by Manufacturer
7.1.1.4. Life Science Analytics Market Production Share by Manufacturer
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Life Science Analytics Market, By Product Type
8.1. Life Science Analytics Market, by Product Type, 2024-2033
8.1.1. Descriptive Analytics
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Predictive Analytics
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Prescriptive Analytics
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Diagnostic Analytics
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Discovery Analytics
8.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Life Science Analytics Market, By Application
9.1. Life Science Analytics Market, by Application, 2024-2033
9.1.1. Services
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Software
9.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Life Science Analytics Market, By End-User
10.1. Life Science Analytics Market, by End-User, 2024-2033
10.1.1. On-premise model
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. On-demand model
10.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Life Science Analytics Market, By Technology
11.1. Life Science Analytics Market, by Technology, 2024-2033
11.1.1. Research & Development
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Preclinical Trials
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Clinical Trials
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Sales & Marketing
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. Regulatory Compliance
11.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Life Science Analytics Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Revenue Forecast by Product (2021-2033)
12.1.2. Market Revenue and Revenue Forecast by Application (2021-2033)
12.1.3. Market Revenue and Revenue Forecast by End-User (2021-2033)
12.1.4. Market Revenue and Revenue Forecast by Technology (2021-2033)
12.1.5. U.S
12.1.5.1. Market Revenue and Revenue Forecast (2021-2033)
12.1.5.2. Market Revenue and Revenue Forecast (2021-2033)
12.1.6. Canada
12.1.6.1. Market Revenue and Revenue Forecast (2021-2033)
12.1.6.2. Market Revenue and Revenue Forecast (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Revenue Forecast by Product (2021-2033)
12.2.2. Market Revenue and Revenue Forecast by Application (2021-2033)
12.2.3. Market Revenue and Revenue Forecast by End-User (2021-2033)
12.2.4. Market Revenue and Revenue Forecast by Technology (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Revenue Forecast (2021-2033)
12.2.5.2. Market Revenue and Revenue Forecast (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Revenue Forecast (2021-2033)
12.2.6.2. Market Revenue and Revenue Forecast (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Revenue Forecast (2021-2033)
12.2.7.2. Market Revenue and Revenue Forecast (2021-2033)
12.2.8. Rest of EU
12.2.8.1. Market Revenue and Revenue Forecast (2021-2033)
12.2.8.2. Market Revenue and Revenue Forecast (2021-2033)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue and Revenue Forecast by Product (2021-2033)
12.3.2. Market Revenue and Revenue Forecast by Application (2021-2033)
12.3.3. Market Revenue and Revenue Forecast by End-User (2021-2033)
12.3.4. Market Revenue and Revenue Forecast by Technology (2021-2033)
12.3.5. China
12.3.5.1. Market Revenue and Revenue Forecast (2021-2033)
12.3.5.2. Market Revenue and Revenue Forecast (2021-2033)
12.3.6. India
12.3.6.1. Market Revenue and Revenue Forecast (2021-2033)
12.3.6.2. Market Revenue and Revenue Forecast (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Revenue Forecast (2021-2033)
12.3.7.2. Market Revenue and Revenue Forecast (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Revenue Forecast (2021-2033)
12.3.8.2. Market Revenue and Revenue Forecast (2021-2033)
12.4. LATAM
12.4.1. Market Revenue and Revenue Forecast by Product (2021-2033)
12.4.2. Market Revenue and Revenue Forecast by Application (2021-2033)
12.4.3. Market Revenue and Revenue Forecast by End-User (2021-2033)
12.4.4. Market Revenue and Revenue Forecast by Technology (2021-2033)
12.4.5. Brazil
12.4.5.1. Market Revenue and Revenue Forecast (2021-2033)
12.4.5.2. Market Revenue and Revenue Forecast (2021-2033)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue and Revenue Forecast (2021-2033)
12.4.6.2. Market Revenue and Revenue Forecast (2021-2033)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue and Revenue Forecast by Product (2021-2033)
12.5.2. Market Revenue and Revenue Forecast by Application (2021-2033)
12.5.3. Market Revenue and Revenue Forecast by End-User (2021-2033)
12.5.4. Market Revenue and Revenue Forecast by Technology (2021-2033)
12.5.5. GCC
12.5.5.1. Market Revenue and Revenue Forecast (2021-2033)
12.5.5.2. Market Revenue and Revenue Forecast (2021-2033)
12.5.6. North Africa
12.5.6.1. Market Revenue and Revenue Forecast (2021-2033)
12.5.6.2. Market Revenue and Revenue Forecast (2021-2033)
12.5.7. South Africa
12.5.7.1. Market Revenue and Revenue Forecast (2021-2033)
12.5.7.2. Market Revenue and Revenue Forecast (2021-2033)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue and Revenue Forecast (2021-2033)
12.5.8.2. Market Revenue and Revenue Forecast (2021-2033)
Chapter 13. Company Profiles
13.1. SAS Institute Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Oracle Corporation
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. Accenture
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. IBM Corporation
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Cognizant, SCIO Health Analytics
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. IQVIA
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Wipro
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. Allscripts Healthcare Solutions
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Cerner Corporation
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. MaxisIT
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample